RIV4 is one of only two available influenza vaccines that ar
egg-free. Like other recombinant vaccines, expression of HA i
insect cells does not depend on the generation of reassortan
candidate vaccine viruses selected for robust growth in embryo
nated eggs or mammalian cell-lines. Instead, HA geneti
sequences from the wild-type strains selected for inclusion i
thevaccineareinsertedintotheBEVS,fromwhichhighyieldso
rHA are harvested and purified (Fig. 1). This process requires les
than half the time (2â€“3 months) required for the manufacture o
conventionalinfluenzavaccines42,43.Thisisacriticaladvantagefo
thetimelysupplyofinfluenzavaccineforbothseasonalepidemic
andinpandemicsituations.VLPshavebeenproducedsuccessfull